RELAY THERAPEUTICS INC (RLAY:NASDAQ)
$18.51 0.02 (0.1082%)
Analysed RELAY THERAPEUTICS INC (RLAY:NASDAQ) News Sources
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June
27-05-2026
yahoo.com
Relay Therapeutics (RLAY) is One of the Best AI Driven Biotech Stocks, Here is Why
11-06-2026
yahoo.com
Relay Therapeutics Insider Sale Tops $3 Million as Shares Surge 500% This Past Year
30-06-2026
fool.com
Relay Therapeutics, Inc. (RLAY) Expected to Beat Earnings Estimates: Should You Buy?
30-07-2026
yahoo.com
Relay Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Updates
06-08-2026
yahoo.com
Relay Therapeutics, Inc. (RLAY) Reports Q2 Loss, Lags Revenue Estimates
06-08-2026
yahoo.com
Relay Therapeutics Stock Is Up Nearly 500% Over the Past Year
13-08-2026
barchart.com
This 'Dynamo' Biotech Puts AI-Fueled Breakout In Motion
21-08-2026
yahoo.com
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September
01-09-2026
yahoo.com
Relay Therapeutics CFO Sells 17,717 Shares for $350,000
02-09-2026
fool.com
What is the current price of RELAY THERAPEUTICS INC (RLAY:NASDAQ)?
The current price of RELAY THERAPEUTICS INC (RLAY:NASDAQ) is $18.51.
RELAY THERAPEUTICS INC (RLAY:NASDAQ) absolute price change since previous trading day?
The absolute price change of RELAY THERAPEUTICS INC (RLAY:NASDAQ) since the previous trading day is $0.02.
RELAY THERAPEUTICS INC (RLAY:NASDAQ) percentage price change since previous trading day?
The percentage price change of RELAY THERAPEUTICS INC (RLAY:NASDAQ) since the previous trading day is 0.1082%.
What is the most recent average sentiment score for RELAY THERAPEUTICS INC (RLAY:NASDAQ)?
The most recent average sentiment score for RELAY THERAPEUTICS INC (RLAY:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for RELAY THERAPEUTICS INC (RLAY:NASDAQ)?
The most recent sentiment for RELAY THERAPEUTICS INC (RLAY:NASDAQ) is .
SEC-8K** Filing Available For RELAY THERAPEUTICS INC (RLAY:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.